Whether it’s consumers, clinicians, or investors, everyone is looking for better ways to see what’s next.
Garmin Goes Screenless
Garmin launched the CIRQA Smart Band, a screenless, subscription-free wearable designed for everyday health tracking.
- Joining products from WHOOP, Oura, Fitbit, and Amazfit, the device shifts the focus away from notifications and toward continuous data collection.
- The launch builds on Garmin’s expanding health platform, which now includes AI coaching, circadian rhythm scoring, sleep insights, and women’s health features.
As screenless wearables gain traction, Garmin is betting the future of health tracking is less about the display and more about the data.
Kalshi Brings Prediction Markets to Biotech
Prediction market platform Kalshi partnered with AppliedXL to launch markets forecasting clinical trial outcomes and FDA decisions.
Instead of betting on a biotech company’s stock, users can trade contracts tied to the success or failure of individual drugs, creating a real-time public probability for clinical and regulatory milestones.
The pilot launches with late-stage trials and includes safeguards around insider trading and market integrity, making drug development transparent, tradable, and available to everyone.
How Much Coffee Is Too Much?
The American Heart Association released new guidance on daily coffee consumption, concluding that three to five cups of black coffee is safe for most adults and may even reduce the risk of heart disease, stroke, and heart failure.
The statement also warns that highly concentrated energy drinks and caffeine shots remain associated with elevated cardiovascular risk.
Nutrition guidance is evolving. Instead of labelling behaviors healthy versus not, researchers are moving toward understanding how dose, context, and individual biology influence outcomes for each individual.
